MiMedx (MDXG) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

How Much Upside Is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12%
Yahoo FinanceNov 20 09:55 ET
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and MiMedx Group (MDXG)
TipRanksNov 17 09:40 ET
Is MiMedx Group (NASDAQ:MDXG) Using Too Much Debt?
Simply Wall StNov 17 08:38 ET
A Quick Look at Today's Ratings for MiMedx(MDXG.US), With a Forecast Between $12 to $16
Moomoo NewsNov 16 08:00 ET · Ratings
Northland Securities Sticks to Their Buy Rating for MiMedx Group (MDXG)
TipRanksNov 15 09:05 ET · Ratings
MiMedx (MDXG) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks Nov 15 07:55 ET

Comments

Bigmoney Dreamer

Nov 14 22:58

$MiMedx (MDXG.US)$ 👀s good intraday consolidation ⚡️crazy move in single day

Stock Region

Mar 4 11:39

Investment Firm Raises Price Target For Major Biotech Company

Mizuho Boosts MiMedx Group's Price Target to $14, Continues Bullish Outlook.
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx (MDXG.US)$
...

Moomoo AI

Mar 4 07:13

MIMEDX's Chair and CEO have expressed optimism about the new appointments, stating that Olson and Puhy will contribute to the company's strategic vision and provide valuable insights. Their skills and leadership records will elevate the Board.

Press Release: MIMEDX Announces Appointment of Two New Independent Directors

Moomoo AI

Jan 22 07:15

CFO Doug Rice asserts the new debt facility offers more flexibility for long-term strategic goals. The terms mirror the company's progress in enhancing its financial profile and reducing interest expense.

Press Release: MIMEDX Announces Improved Capital Structure With New Senior Secured Credit Facilities and Debt Refinancing

Moomoo AI

Dec 21, 2023 01:30

Analysts say that MiMedx's low projected revenue growth may contribute to its weak P/S ratio. Significant performance improvements would be needed for a potential P/S ratio rise. The low P/S ratio casts doubt on the company's potential despite its share price increase.

MiMedx Group, Inc. (NASDAQ:MDXG) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

1

MDXG MiMedx

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target